» Articles » PMID: 37289231

Assessing Prevalence and Characteristics of Oro-bulbar Involvement in Children and Adults with SMA Type 2 and 3 Using a Multimodal Approach

Abstract

Bulbar and jaw muscles are impaired in patients with Spinal Muscular Atrophy (SMA) but the assessment of their severity and progression are limited by the lack of age-appropriate and disease-specific measures. We investigated mastication and swallowing in children and adults with SMA, sitters and walkers. In a 2-year multicentre cross-sectional prospective study, lip and tongue strength (Iowa Oral Performance Instrument), chewing and swallowing (Test of Masticating and Swallowing Solids), active mouth opening (aMMO) were compared to age-appropriate normative data. The perceived burden of oro-bulbar involvement (SMA-Health Index) was recorded. 78 patients were included, 45 children (median age 7.4 years),22 adults (median age 26.8 years) on nusinersen and 11 untreated (median age 32.7 years). Forty-three percent children had reduced mouth opening, 50% had prolonged total time to eat. These issues were more prominent in sitters than in walkers (p = 0.019, p = 0.014). Sixty-six percent needed increased swallows for bolus clearance. Nusinersen treated adults had median aMMO, tongue strength and total time at TOMASS values within normal range (z score: -1.40, -1.22, -1.32, respectively) whereas untreated adults had reduced aMMO (z score: -2.68) and tongue strength (z score: -2.20). Only a minority of children (2/17) and treated adults (5/21) reported burden in swallowing or mastication compared to all untreated adults (5/5). After 16 months, mastication and swallowing were stable in treated children and adults, whether sitters or walkers. The reported multimodal approach to assess oro-bulbar functions demonstrate that swallowing and mastication are impaired in SMA despite patients' perception. These results suggest a trend towards stabilization of oro-bulbar function in patients on long-term treatment with nusinersen.

Citing Articles

Maximal mouth opening in infants and toddlers with spinal muscular atrophy: a prospective controlled study.

Zang J, Weiss D, Dumitrascu C, Glinzer J, Wegner M, Strube A Orphanet J Rare Dis. 2025; 20(1):24.

PMID: 39815373 PMC: 11734460. DOI: 10.1186/s13023-024-03524-z.


Swallowing function in patients with spinal muscular atrophy before and after the introduction of new gene-based therapies: what has changed?.

Ruggiero M, Giannotta G, Pirani G, Saponaro F, Oliva M, Ferrante C Neurol Sci. 2024; 46(3):1137-1149.

PMID: 39630343 PMC: 11828825. DOI: 10.1007/s10072-024-07883-0.


Assessing the Swallowing Function in Children with Spinal Muscular Atrophy: An Easily Accessible and Objective Multidimensional Approach.

Colot C, Benmechri S, Everaert E, Muys S, Van Himme L, Tahon V J Neuromuscul Dis. 2024; 11(4):839-853.

PMID: 38701158 PMC: 11307076. DOI: 10.3233/JND-240017.


Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment.

Brakemeier S, Lipka J, Schlag M, Kleinschnitz C, Hagenacker T J Neurol. 2024; 271(5):2649-2657.

PMID: 38358553 PMC: 11055773. DOI: 10.1007/s00415-024-12203-9.

References
1.
Mercuri E, Finkel R, Muntoni F, Wirth B, Montes J, Main M . Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018; 28(2):103-115. DOI: 10.1016/j.nmd.2017.11.005. View

2.
Chen Y, Shih H, Chen T, Kuo C, Jong Y . Prevalence and risk factors for feeding and swallowing difficulties in spinal muscular atrophy types II and III. J Pediatr. 2011; 160(3):447-451.e1. DOI: 10.1016/j.jpeds.2011.08.016. View

3.
Dunaway Young S, Montes J, Kramer S, Podwika B, Rao A, De Vivo D . Perceived Fatigue in Spinal Muscular Atrophy: A Pilot Study. J Neuromuscul Dis. 2018; 6(1):109-117. DOI: 10.3233/JND-180342. View

4.
van Bruggen H, van den Engel-Hoek L, van der Pol W, de Wijer A, de Groot I, Steenks M . Impaired mandibular function in spinal muscular atrophy type II: need for early recognition. J Child Neurol. 2011; 26(11):1392-6. DOI: 10.1177/0883073811407696. View

5.
de Onis M, Lobstein T . Defining obesity risk status in the general childhood population: which cut-offs should we use?. Int J Pediatr Obes. 2010; 5(6):458-60. DOI: 10.3109/17477161003615583. View